- 2022, Volume 80 - Number 3
- Published: October 24, 2022
Intralesional triamcinolone acetonide for alopecia areata: does dilution matter?
Rebeca Calado 1, Rui Oliveira Soares 2
1 Department of Dermatology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal; 2 Department of Dermatology, Hospital CUF Descobertas. Lisbon, Portugal
Rebeca Calado, Rui Oliveira Soares
La información completa de afiliaciones y autor de correspondencia está disponible en la versión original en PDF.
*Correspondence: Rebeca Calado, Email not available
Abstract
Alopecia areata (AA) is a chronic, remitting, non-scarring form of alopecia, which can be associated with significant emotional distress. Intralesional corticosteroids, particularly triamcinolone acetonide, remain first-line therapy in adults with limited, patchy alopecia areata. However, the optimal concentration of intralesional corticosteroids has not yet been fully elucidated. In this manuscript, we examine current evidence about this matter to guide clinical decision-making.
